HN2007000505A - Analogos de pirazol - Google Patents
Analogos de pirazolInfo
- Publication number
- HN2007000505A HN2007000505A HN2007000505A HN2007000505A HN2007000505A HN 2007000505 A HN2007000505 A HN 2007000505A HN 2007000505 A HN2007000505 A HN 2007000505A HN 2007000505 A HN2007000505 A HN 2007000505A HN 2007000505 A HN2007000505 A HN 2007000505A
- Authority
- HN
- Honduras
- Prior art keywords
- pirazol
- analogs
- procedures
- compositions
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS, COMPOSICIONES Y PROCEDIMIENTOS PARA TRATAR ENFERMEDADES Y AFECCIONES, EN PARTICULAR SE REFIERE A COMPUESTOS, COMPOSICIONES Y PROCEDIMIENTOS PARA TRATAR ENFERMEDADES, TRASTORNOS Y AFECCIONES ALERGICOS Y RESPIRATORIOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86733706P | 2006-11-27 | 2006-11-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
HN2007000505A true HN2007000505A (es) | 2010-06-09 |
Family
ID=39226772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HN2007000505A HN2007000505A (es) | 2006-11-27 | 2007-11-26 | Analogos de pirazol |
Country Status (32)
Country | Link |
---|---|
US (1) | US7772269B2 (es) |
EP (1) | EP2097407A1 (es) |
JP (1) | JP4469924B2 (es) |
KR (1) | KR20090074264A (es) |
CN (1) | CN101541790A (es) |
AP (1) | AP2009004849A0 (es) |
AR (1) | AR063924A1 (es) |
AU (1) | AU2007327004A1 (es) |
BR (1) | BRPI0718672A2 (es) |
CA (1) | CA2667566C (es) |
CL (1) | CL2007003403A1 (es) |
CO (1) | CO6180447A2 (es) |
CR (1) | CR10745A (es) |
CU (1) | CU23801B7 (es) |
DO (1) | DOP2009000121A (es) |
EA (1) | EA016588B1 (es) |
EC (1) | ECSP099328A (es) |
GE (1) | GEP20125386B (es) |
GT (1) | GT200700104A (es) |
HN (1) | HN2007000505A (es) |
IL (1) | IL198412A0 (es) |
MA (1) | MA30924B1 (es) |
MX (1) | MX2009005526A (es) |
NO (1) | NO20092413L (es) |
NZ (1) | NZ576376A (es) |
PE (1) | PE20081299A1 (es) |
RS (1) | RS20090211A (es) |
TN (1) | TN2009000205A1 (es) |
TW (1) | TW200831495A (es) |
UA (1) | UA92833C2 (es) |
UY (1) | UY30743A1 (es) |
WO (1) | WO2008065493A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009069044A1 (en) | 2007-11-26 | 2009-06-04 | Pfizer Inc. | Pyrazole derivatives as 5-lo inhibitors |
EP2151450A1 (de) * | 2008-07-29 | 2010-02-10 | Sandoz AG | Verfahren zur Aufarbeitung von mikrobiologisch hergestellten zyklischen Oligopeptiden |
EP2563359A1 (en) * | 2010-04-30 | 2013-03-06 | Allergan, Inc. | Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase |
TWI527809B (zh) * | 2011-01-24 | 2016-04-01 | 百靈佳殷格翰國際股份有限公司 | 作為crth2拮抗劑之吡唑化合物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE913866A1 (en) * | 1990-11-28 | 1992-06-03 | Ici Plc | Aryl derivatives |
PL175987B1 (pl) | 1993-06-14 | 1999-03-31 | Pfizer | Nowe imidazolowe inhibitory lipoksygenazy |
US5883106A (en) | 1994-10-18 | 1999-03-16 | Pfizer Inc. | 5-lipoxygenase inhibitors |
JP3400392B2 (ja) * | 1994-10-18 | 2003-04-28 | ファイザー製薬株式会社 | 5−リポキシゲナーゼ阻害剤及び新規医薬組成物 |
SK281577B6 (sk) * | 1994-10-18 | 2001-05-10 | Pfizer Inc. | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze |
US6037355A (en) | 1995-09-18 | 2000-03-14 | Pfizer Inc | Imidazole lipoxygenase inhibitors |
US6194585B1 (en) * | 1998-12-22 | 2001-02-27 | Pfizer Inc. | Process for preparing 5-lipoxygenase inhibitors |
JP2001100682A (ja) * | 1999-09-28 | 2001-04-13 | Sanyo Electric Co Ltd | サインシステム |
JP2001100686A (ja) * | 1999-09-28 | 2001-04-13 | Hitachi Kokusai Electric Inc | 表示データ取込方法及び比較検査装置 |
-
2007
- 2007-11-14 RS RSP-2009/0211A patent/RS20090211A/sr unknown
- 2007-11-14 EA EA200970422A patent/EA016588B1/ru not_active IP Right Cessation
- 2007-11-14 GE GEAP200711271A patent/GEP20125386B/en unknown
- 2007-11-14 UA UAA200903927A patent/UA92833C2/ru unknown
- 2007-11-14 BR BRPI0718672-0A patent/BRPI0718672A2/pt not_active IP Right Cessation
- 2007-11-14 AU AU2007327004A patent/AU2007327004A1/en not_active Abandoned
- 2007-11-14 AP AP2009004849A patent/AP2009004849A0/xx unknown
- 2007-11-14 MX MX2009005526A patent/MX2009005526A/es active IP Right Grant
- 2007-11-14 WO PCT/IB2007/003518 patent/WO2008065493A1/en active Application Filing
- 2007-11-14 KR KR1020097010726A patent/KR20090074264A/ko not_active Application Discontinuation
- 2007-11-14 NZ NZ576376A patent/NZ576376A/en not_active IP Right Cessation
- 2007-11-14 CA CA2667566A patent/CA2667566C/en not_active Expired - Fee Related
- 2007-11-14 EP EP07848899A patent/EP2097407A1/en not_active Withdrawn
- 2007-11-14 JP JP2009538801A patent/JP4469924B2/ja not_active Expired - Fee Related
- 2007-11-14 CN CNA2007800432018A patent/CN101541790A/zh active Pending
- 2007-11-23 AR ARP070105216A patent/AR063924A1/es not_active Application Discontinuation
- 2007-11-26 PE PE2007001660A patent/PE20081299A1/es not_active Application Discontinuation
- 2007-11-26 GT GT200700104A patent/GT200700104A/es unknown
- 2007-11-26 US US11/944,732 patent/US7772269B2/en not_active Expired - Fee Related
- 2007-11-26 HN HN2007000505A patent/HN2007000505A/es unknown
- 2007-11-26 UY UY30743A patent/UY30743A1/es not_active Application Discontinuation
- 2007-11-26 TW TW096144833A patent/TW200831495A/zh unknown
- 2007-11-27 CL CL200703403A patent/CL2007003403A1/es unknown
-
2009
- 2009-04-23 CR CR10745A patent/CR10745A/es not_active Application Discontinuation
- 2009-04-27 IL IL198412A patent/IL198412A0/en unknown
- 2009-05-13 EC EC2009009328A patent/ECSP099328A/es unknown
- 2009-05-15 CU CU20090083A patent/CU23801B7/es not_active IP Right Cessation
- 2009-05-20 CO CO09051941A patent/CO6180447A2/es not_active Application Discontinuation
- 2009-05-22 TN TNP2009000205A patent/TN2009000205A1/fr unknown
- 2009-05-26 DO DO2009000121A patent/DOP2009000121A/es unknown
- 2009-05-27 MA MA31925A patent/MA30924B1/fr unknown
- 2009-06-24 NO NO20092413A patent/NO20092413L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200900095A (es) | Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas. | |
PA8772101A1 (es) | Imidazol-triazolopirimidinas sustituidas | |
WO2007142755A3 (en) | Purine analogs | |
PA8660301A1 (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion | |
UA113165C2 (xx) | Застосування комбінації баклофену і акампросату для лікування неврологічних захворювань та композиція, яка містить баклофен і акампросат | |
CR11472A (es) | 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso | |
CL2008000789A1 (es) | Compuestos derivados de adenina; composicion farmaceutica que comprende a dichos compuestos, utiles para tratar enfermedades alergicas, virales o cancer, entre otras. | |
BR112015010663A2 (pt) | formas de dosagem de ruxolitinib de liberação sustentada | |
BRPI0812755A2 (pt) | Compostos de derivados de fenil alquinila para tratar doenças, e desordens oftálmicas | |
DOP2005000025A (es) | Compuestos de heteroaril- y fenilsulfamoilo sustituidos | |
CO6400193A2 (es) | Dicianopiridinas alquilamino-sustituidas y sus profármacos de éster de aminoácido | |
MX2010005931A (es) | Profarmacos de tetrahidrocanabinol, composiciones que comprenden profarmacos de tetrahidrocanabinol y metodos para utilizar los mismos. | |
PA8770101A1 (es) | Amidas de 4-aril-1,4-dihidro-1, 6-naftiridina sustituidas y su uso | |
BRPI0818799A2 (pt) | Composições para o tratamento da doença de parkinson | |
ECSP10010582A (es) | Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer | |
WO2013016668A3 (en) | Methylphenidate-prodrugs, processes of making and using the same | |
DOP2007000053A (es) | Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo | |
HN2010002518A (es) | Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina | |
BRPI0820668A2 (pt) | Derivados de oxindol substituídos por 5-halogênio e seu uso para tratar doenças dependentes de vasopressina | |
CR10305A (es) | "derivados sustituidos de cromanol y su uso. | |
BRPI0911577A2 (pt) | derivados espiro-indol para o tratamento de doenças parasíticas. | |
BR112014005025A2 (pt) | composição farmacêutica para uso no tratamento de uma doença neurodegenerativa | |
HN2009003424A (es) | (oxazolidinon-5-il-metil) -2-tiofen-carboxamidas sustituida y su uso en el campo de la coagulacion sanguinea | |
BRPI0917440A2 (pt) | composições farmacêuticas oftálmicas para o tratamento de patologias neoangiogênicas do olho | |
BR112013022052A2 (pt) | ligantes antagonísticos de dr3 |